Anish Patel, CHIEF OPERATING OFFICER at Enliven Therapeutics, Inc. (ELVN), sold 9,750 shares at $15.11 ($147K) on 2024-02-06, disclosed to the SEC on 2024-02-08.
Scheduled sale ($147k) by CHIEF OPERATING OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.11 | 4,875 | $74K | 50.0% |
| 2 | $15.11 | 4,875 | $74K | 50.0% |
| Total | $15.11 avg | 9,750 | $147K | 100% |
| Filing → |
| ELVN | SELL | 2025-11-12 | $221K | — | Filing → |
| ELVN | SELL | 2025-10-09 | $268K | — | Filing → |
| ELVN | SELL | 2025-09-10 | $270K | — | Filing → |